论文部分内容阅读
随着经济的日益发展和人们生活方式的转变,糖尿病已经成为中国最重要的公共卫生问题之一。值此之际,由中华医学会和中山大学支持、默沙东和中山大学附属第三医院联合牵头进行糖尿病STRATEGY临床研究,中华医学会罗玲副秘书长指出,“STRATEGY研究的开展不仅为积累中国糖尿病数据、规范临床防治实现了里程碑式的突破,更为《中国2型糖尿病防治指南》的进一步实践贡献了力量”预计该研究历时2年,拟覆盖中国多个大、中城市近300家研究中心,
As the economy continues to grow and people’s lifestyle changes, diabetes has become one of the most important public health problems in China. In the meantime, supported by the Chinese Medical Association and Sun Yat-sen University, Merck and the Third Affiliated Hospital of Sun Yat-sen joint lead diabetes STRATEGY clinical research, Chinese Medical Association, Luo Ling, deputy secretary-general pointed out that “STRATEGY study not only for the accumulation of China Diabetes data, standardize clinical prevention and treatment to achieve a milestone in the breakthrough, more ”China Type 2 Diabetes Prevention Guide“ contribute to the further practice of practice ”is expected to study for 2 years, to be covered in China, a number of large and medium-sized cities, nearly 300 Research center,